7 news items
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
GUTS
20 May 24
to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health's goal is to transform metabolic disease treatment from chronic
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
GUTS
13 May 24
Health's goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
GUTS
13 May 24
of morbidity and mortality in the 21st century. Fractyl Health's goal is to transform metabolic disease treatment from chronic symptomatic management
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
GUTS
8 May 24
and mortality in the 21st century. Fractyl Health's goal is to transform metabolic disease treatment from chronic symptomatic management to durable
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
GUTS
7 May 24
, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health's goal is to transform metabolic
7nftwcizx2et5v0qh011r2eayduxsved2bbs
GUTS
30 Apr 24
and TD2 continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health's goal is to transform metabolic disease
z8ugy vxl6i0aialea4
GUTS
1 Apr 24
the last 50 years, T2D and obesity continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health's goal
- Prev
- 1
- Next